Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05548452 · ClinicalTrials.gov registry record · Phase 1
Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
A Phase 1 study of Alcohol Use Disorder and Cirrhosis, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT05548452 is a Phase 1 study of Alcohol Use Disorder and Cirrhosis that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 80 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05548452, a Phase 1 study of Alcohol Use Disorder and Cirrhosis, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.
Conditions Studied
Interventions
- DRUG Intestinal Microbiota Transplant (IMT) Capsules
- DRUG Placebo Capsules
Study Locations (2)
Virginia
- Hunter Holmes McGuire VA Medical Center - Richmond
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-11-21 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05548452
The ClinicalTrials.gov registry entry for NCT05548452 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (76% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Intestinal Microbiota Transplant (IMT) Capsules is the first listed.
NCT05548452 reports 2 study locations spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05548452 about?
NCT05548452 is a clinical study titled "Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease". The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.
What is the current status of trial NCT05548452?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2022-11-21. Estimated completion is 2026-12-30.
What conditions does trial NCT05548452 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Cirrhosis, Liver Disease; Alcohol-Related.
What interventions are being tested in trial NCT05548452?
The interventions under investigation include: Intestinal Microbiota Transplant (IMT) Capsules (DRUG), Placebo Capsules (DRUG).
Who is sponsoring clinical trial NCT05548452?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05548452 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intranasal Insulin for Treatment of Alcohol Use Disorder
RECRUITING · Phase 1
-
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
RECRUITING · Phase 1
-
Environment and Alcohol: A Pilot Study
RECRUITING · Phase 1
-
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
RECRUITING · Phase 1
-
Sex Differences in the Response to Abstinence From Alcohol.
RECRUITING · Phase 1
-
PT150 Drug for Use in Alcohol Use Disorder
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.